Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report.

Chi-E Qiu, Lei Lei, Guosong Jiang, Xiuqun Huang, Yadan Li

Abstract readCase Reports

In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chi-E Qiu *Hematology Department, Northeast Yunnan Central Hospital, Zhaotong, Yunnan, China.

Lei Lei *Hematology Department, Northeast Yunnan Central Hospital, Zhaotong, Yunnan, China.

Guosong JiangDepartment of Pulmonary and Critical Care Medicine, The First People's Hospital of Zhaotong & The Zhaotong Affiliated Hospital of Kunming Medical University, Zhaotong, Yunnan, China.

Xiuqun HuangClinical Laboratory, The First People's Hospital of Zhaotong & The Zhaotong Affiliated Hospital of Kunming Medical University, Zhaotong, Yunnan, China.

Yadan LiHematology Department, Northeast Yunnan Central Hospital, Zhaotong, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary spherocytosis (HS) is a genetic hemolytic disorder primarily characterized by hemolytic anemia, jaundice, splenomegaly, and frequent complications, including cholelithiasis, accompanied by the presence of spherocytes in the peripheral blood. This disorder predominantly follows an autosomal dominant inheritance pattern; however, certain cases exhibit an autosomal recessive mode of inheritance. HS is the most prevalent disorder associated with defects in the red blood cell membrane. Primary myelofibrosis (PMF), a chronic myeloproliferative neoplasm (MPN) characterized by splenomegaly resulting from extramedullary hematopoiesis, is associated with the

Indexed as

comorbidityhereditary spherocytosisJAK2V617Fmyeloproliferative neoplasmprimary myelofibrosis

Identifiers

PMID41179685

DOI10.3389/fonc.2025.1665179

PMCPMC12575200

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.